PricewaterhouseCoopers Acquires Surfaceink In Strategic Transaction

ACQUISITION IMAGE: Bob Moritz & Eric Bauswell DATE: 12/11/2023 BUYER: PricewaterhouseCoopers (PwC) SELLER: Surfaceink SALE PRICE: XXX,XXX,XXX NOTE: PricewaterhouseCoopers (PwC) is acquiring Silicon Valley tech company Surfaceink, once a key Apple hardware engineering partner during Steve Jobs' CEO tenure. While the acquisition price remains undisclosed, Surfaceink, renowned for hardware design, will bring its expertise and CEO Eric Bauswell to PwC, along with about 50 Bay Area employees. Surfaceink's clientele includes tech giants like Amazon, Apple, Google, and Microsoft. PwC, traditionally not in hardware, aims to utilize Surfaceink's capabilities to engage with hardware-focused clients, reflecting industry dynamics and aligning with PwC's growth strategy. Founded in 1999, Surfaceink played a vital role in Apple collaborations, and this acquisition, occurring during a strategic refresh, opens new opportunities for both companies. PricewaterhouseCoopers (PwC) HQ: #London #UnitedKingdom Surfaceink: #SiliconValley #California #VentureCapital #BobMoritz #EricBauswell #PricewaterhouseCoopers #PwC #Surfaceink #TradedVC

More Deals

View All

Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts. FOUNDERS: Ben Lamm & George Church TARGET VALUATION: $23,000,000,000 HQ: Dallas, Texas #VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC